Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Therapy response in AML: a tale of two T cells

Livius Penter, Catherine J. Wu

Blood (2024) 144 (11): 1134–1136.

https://doi.org/10.1182/blood.2024024593

Published: 2024

Journal Articles

Baseline Immune State and T-cell Clonal Kinetics are Associated with Durable Response to CAR-T Therapy in Large B-cell Lymphoma

Blood blood.2024024381.

https://doi.org/10.1182/blood.2024024381

Published: 2024

Includes: Supplemental data

Journal Articles

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

Blood (2024) 143 (13): 1231–1241.

https://doi.org/10.1182/blood.2023022204

Published: 2024

Includes: Supplemental data

Journal Articles

ASXL1 Truncating Mutations Drive Leukemic Resistance to T Cell Attack

Blood (2023) 142 (Supplement 1): 364.

https://doi.org/10.1182/blood-2023-189177

Published: 2023

Journal Articles

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Blood (2023) 142 (Supplement 1): 361.

https://doi.org/10.1182/blood-2023-187705

Published: 2023

Journal Articles

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Alexandria Maurer, Cameron Y Park, Shouvik Mani, Mehdi Borji, Crystal Shin, Livius Penter, James R Brenner, Jackson Southard, Wesley S Lu, Haoxiang Lyu, Shuqiang Li, Kenneth J. Livak, Jerome Ritz, Robert J. Soiffer, Elham Azizi, Catherine J Wu

Blood (2023) 142 (Supplement 1): 363.

https://doi.org/10.1182/blood-2023-189292

Published: 2023

Journal Articles

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

Livius Penter, Nicoletta Cieri, Katie Maurer, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Caleb Lareau, Leif S Ludwig, Shuqiang Li, Jerome Ritz, Jacqueline S. Garcia, Robert J. Soiffer, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 3580.

https://doi.org/10.1182/blood-2023-180113

Published: 2023

Journal Articles

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2023-181863

Published: 2023

Journal Articles

Baseline Immune State and T Cell Clonal Kinetics Are Associated with Response to CAR-T Therapy in Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 223.

https://doi.org/10.1182/blood-2023-180819

Published: 2023

Journal Articles

Unraveling the Dynamics of T Cell-Dependent Bispecific Antibodies in Multiple Myeloma: Multi-Omic Insights from Primary Patient Cells

Dennis J Wu, Amy S Chen, Nikki Deangelis, Diana Cortes, Jose Morachis, Benjamin Titz, Sylvaine Cases, Raluca Verona, Chorom Pak

Blood (2023) 142 (Supplement 1): 3659.

https://doi.org/10.1182/blood-2023-190245

Published: 2023

Journal Articles

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Livius Penter, Mehdi Borji, Adi Nagler, Haoxiang Lyu, Wesley S Lu, Nicoletta Cieri, Alexandria Maurer, Giacomo Oliveira, Aziz M. Al'Khafaji, Kiran Garimella, Shuqiang Li, Donna S. Neuberg, Jerome Ritz, Robert J. Soiffer, Jacqueline S. Garcia, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 1596.

https://doi.org/10.1182/blood-2023-180016

Published: 2023

Journal Articles

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 652.

https://doi.org/10.1182/blood-2023-187451

Published: 2023

Journal Articles

Real-World Outcomes of Brexucabtagene Autoleucel (Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics

Blood (2023) 142 (Supplement 1): 107.

https://doi.org/10.1182/blood-2023-179269

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison (MAIC) of Brexucabtagene Autoleucel (Brexu-cel) and Pirtobrutinib in Patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (cBTKi)

Jenny M.H. Chen, Ina Zhang, James J. Wu, Sally W. Wade, Ana Nunes, Weimin Peng, Julia T. Snider, Dylan Maciel, Keith Chan, Sam Keeping, Bijal D. Shah

Blood (2023) 142 (Supplement 1): 5136.

https://doi.org/10.1182/blood-2023-177741

Published: 2023

Journal Articles

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

Francesco Mazziotta, Lauren E Martin, Miranda Lahman, Daniel N. Egan, Sinéad Kinsella, Kelly Paulson, Yapeng Su, Valentin Voillet, Livius Penter, Catherine J Wu, Philip Greenberg, Aude G Chapuis

Blood (2023) 142 (Supplement 1): 4849.

https://doi.org/10.1182/blood-2023-189773

Published: 2023

Journal Articles

Richter syndrome: novel insights into the biology of transformation

Erin M. Parry, Elisa ten Hacken, Catherine J. Wu

Blood (2023) 142 (1): 11–22.

https://doi.org/10.1182/blood.2022016502

Published: 2023

Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Blood (2023) 141 (15): 1884–1888.

https://doi.org/10.1182/blood.2022017686

Published: 2023

Includes: Supplemental data

Journal Articles

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Blood (2023) 141 (15): 1817–1830.

https://doi.org/10.1182/blood.2022018246

Published: 2023

Includes: Supplemental data

Journal Articles

The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia

Adi Nagler, Catherine J. Wu

Blood (2023) 141 (4): 369–379.

https://doi.org/10.1182/blood.2021014669

Published: 2023

Journal Articles

Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, José I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott

Blood (2022) 140 (21): 2193–2227.

https://doi.org/10.1182/blood.2022015854

Published: 2022

Includes: Supplemental data

NARROW

Therapy response in AML: a tale of two T cells

Baseline Immune State and T-cell Clonal Kinetics are Associated with Durable Response to CAR-T Therapy in Large B-cell Lymphoma

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

ASXL1 Truncating Mutations Drive Leukemic Resistance to T Cell Attack

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Baseline Immune State and T Cell Clonal Kinetics Are Associated with Response to CAR-T Therapy in Large B-Cell Lymphoma

Unraveling the Dynamics of T Cell-Dependent Bispecific Antibodies in Multiple Myeloma: Multi-Omic Insights from Primary Patient Cells

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Real-World Outcomes of Brexucabtagene Autoleucel (Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics

Matching-Adjusted Indirect Comparison (MAIC) of Brexucabtagene Autoleucel (Brexu-cel) and Pirtobrutinib in Patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (cBTKi)

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

Richter syndrome: novel insights into the biology of transformation

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia

Genomic profiling for clinical decision making in lymphoid neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only